Moderna (LIM:MRNA) Purchase Of Property, Plant, Equipment : $-790 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Moderna Purchase Of Property, Plant, Equipment?

Moderna's purchase of property, plant, equipment for the three months ended in Mar. 2024 was $-196 Mil. It means Moderna spent $196 Mil on purchasing property, plant, equipment. Moderna's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was $-790Mil.

Compared with last quarter ($-220 Mil in Dec. 2023 ), Moderna spent less money on purchasing property, plant, equipment in Mar. 2024 ($-196 Mil).

Moderna Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Moderna's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Purchase Of Property, Plant, Equipment Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Get a 7-Day Free Trial

-32.00

-68.00

-284.00

-400.00

-707.00

Moderna Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial															-113.00	-234.00	-140.00	-220.00	-196.00

Moderna Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-790 Mil.

Moderna Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Moderna's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna (LIM:MRNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (LIM:MRNA) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Mexico 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.